Since 2013, we have also been working on expanding access to testing and treatment for HIV, hepatitis C and sexually transmitted diseases.

In Tashkent, the capital, and the surrounding region, we initiated outreach activities to engage with people from high-risk groups. As well as assisting with saliva-based self-testing for HIV and hepatitis C, we provide them with information on infection prevention and risk-reduction strategies.

Our outreach teams also offer support to people requiring laboratory testing and medical care. In collaboration with the Republican AIDS centre, we operate a mobile laboratory in a specially equipped bus, where we carry out rapid testing for HIV, hepatitis C and syphilis. In addition, we provide information on treatment options and specialist referrals, addressing the needs of those who might otherwise have difficulty in obtaining diagnosis and care. Meanwhile, at Tashkent AIDS centre, we continue to support the diagnosis and treatment of people living with HIV and co-infections.

In Karakalpakstan, we run a comprehensive care programme for patients with drug-resistant forms of TB. In December 2022, the World Health Organization recommended the programmatic use of a new, six-month, all-oral treatment regimen for drug-resistant TB, which is safer and more effective than other treatment regimens in use. In 2023, we ensured that all eligible patients with multidrug-resistant TB in Karakalpakstan received treatment using the new regimen, and will continue to support its rollout countrywide.